Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein-Barr virus

被引：24
|
作者：
Katzman, RB [1 ]
Longnecker, R [1 ]
机构：
[1] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA
来源：
JOURNAL OF GENERAL VIROLOGY | 2003年 / 84卷
关键词：
D O I：
10.1099/vir.0.19252-0
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Epstein-Barr virus (EBV) infection is a multi-step process, first requiring virus binding to the host cell, followed by fusion of the viral envelope with the host cell plasma membrane. Efficient EBV entry into B cells requires, at the minimum, the interaction of the EBV-encoded glycoproteins gp350 with cellular CD21 and gp42 with MHC class II proteins. In this study, use of the cholesterol-binding drugs methyl-beta-cyclodextrin and nystatin efficiently inhibited EBV infection of target Burkitt's lymphoma B-cell lines, indicating an important role for cholesterol and suggesting the involvement of lipid rafts in EBV infection.
引用
收藏
页码：2987 / 2992
页数：6
相关论文
共 50 条
  • [41] Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells
    Maruo, S
    Nanbo, A
    Takada, K
    JOURNAL OF VIROLOGY, 2001, 75 (20) : 9977 - 9982
  • [42] Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers
    Bornkamm, Georg W.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (08) : 1745 - 1755
  • [43] Expression of Epstein-Barr virus gene products in Burkitt's lymphoma in Northeast Brazil
    Araujo, I
    Foss, HD
    Bittencourt, A
    Hummel, M
    Demel, G
    Mendonca, N
    Herbst, H
    Stein, H
    BLOOD, 1996, 87 (12) : 5279 - 5286
  • [44] Malaria, Epstein-Barr virus, vitamin A and Burkitt's lymphoma: Response to Joob and Wiwanitkit
    Mawson, Anthony R.
    Majumdar, Suvankar
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (04) : 864 - 864
  • [45] EPSTEIN-BARR VIRUS-POSITIVE JAPANESE BURKITT-LYMPHOMA
    MIYOSHI, I
    HIRAKI, S
    TSUBOTA, T
    UNO, J
    NAKAMURA, K
    OTA, T
    HIKITA, T
    HAYASHI, K
    KATAOKA, M
    TANAKA, T
    KIMURA, I
    SAIRENJI, T
    HINUMA, Y
    GANN, 1978, 69 (03): : 449 - 450
  • [46] DEMONSTRATION OF EPSTEIN-BARR VIRUS GENOME IN EUROPEAN BURKITT-LYMPHOMA
    WUTZLER, P
    SPROSSIG, M
    HIRSCH, J
    BRICHACEK, B
    VONKA, V
    SCHINDLER, E
    WUTKE, K
    RUDIGER, KD
    WOCKEL, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 105 (27) : 961 - 966
  • [47] Pediatric Burkitt lymphoma with concurrent chronic Epstein-Barr virus hepatitis
    Preciado, MV
    De Matteo, E
    Freigeiro, D
    Galoppo, C
    Saúl, G
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 33 (02): : 134 - 136
  • [48] Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt’s lymphoma cell lines
    A. Mochida
    E. Gotoh
    H. Senpuku
    S. Harada
    R. Kitamura
    T. Takahashi
    K. Yanagi
    Archives of Virology, 2005, 150 : 2139 - 2150
  • [49] Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines
    Mochida, A
    Gotoh, E
    Senpuku, H
    Harada, S
    Kitamura, R
    Takahashi, T
    Yanagi, K
    ARCHIVES OF VIROLOGY, 2005, 150 (10) : 2139 - 2150
  • [50] Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient
    Hunt, BJ
    Thomas, JA
    Burke, M
    Walker, H
    Yacoub, M
    Crawford, DH
    TRANSPLANTATION, 1996, 62 (06) : 869 - 872
12345